Peijia Medical Limited
Research Peijia Medical Limited (4WO) on Bullrun: market cap EUR 351.49M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4WO
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 351.49M
- Financial periodFY2025
- RevenueCNY 712.87M
- Revenue growth15.8%
- Net income-CNY 203.29M
- Free cash flow-CNY 325.28M
- Gross margin68.2%
Valuation Snapshot
latest market cap is EUR 351.49M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 712.87M | -CNY 203.29M | -CNY 325.28M | 68.2% | -0.31 | CNY 536.73M | CNY 434.03M | CNY 1.84B |
| FY2024 | CNY 615.48M | -CNY 226.58M | -CNY 285.29M | 70.5% | -0.34 | CNY 666.74M | CNY 253.40M | CNY 2.03B |
| FY2023 | CNY 441.13M | -CNY 392.53M | -CNY 947.10M | 73.8% | -0.58 | CNY 795.77M | CNY 221.14M | CNY 2.27B |
| FY2022 | CNY 250.83M | -CNY 407.81M | -CNY 578.54M | 70.2% | -0.61 | CNY 1.67B | CNY 131.88M | CNY 2.64B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 351.49M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Peijia Medical Limited's market cap?
Peijia Medical Limited's market capitalization is EUR 351.49M.
What does Peijia Medical Limited do?
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments.